TROFI: Minimal intra-stent flow area in STEMI patients post primary PCI with or without manual thrombus aspiration.

Professor Serruys presented the results of the TROFI trial that compares the minimal intra-stent flow area in STEMI patients post primary PCI with or without manual thrombus aspiration.

The minimal intra-stent flow area helps assess thrombus burden and is defined as: (stent area + incomplete stent apposition area) – (intralulminal defect area attached to the wall + intraluminal defect area free from the wall + tissue prolapse area). 

To measure the minimal flow area, researchers used a novel technology called ODFI (optical domain frequency imaging), an invasive tool that generates precise high resolution images (180 µ) capable of detecting and quantifying thrombi in stent lumen at implantation.

141 patients were randomized (1:1) to primary PCI with or without thrombectomy. After an optimal angiographic result, all patients were submitted to ODFI. The minimal flow area post stenting did not show significant variation (7,08±2,14 with thrombectomy vs. 6,51±1,99 without thrombectomy, P=0,12).

Conclusion: thrombectomy significantly reduced the impact of thrombus according to minimal flow area post-stenting. The use of this promising novel technology allows the assessment of intracoronary thrombi during PCI.

Serruys_x_430392-1
P. Serruys
2012-05-16

More articles by this author

DISCOVER FLOW: Correlation of conventional FFR vs non invasive FFR obtained with MSCT for successful stenting.

The DISCOVER FLOW trial has recently showed an excellent correlation between fractional flow reserve values (FFR) traditionally obtained with coronary CT angiography (CCTA) and...

CLI-OPCI: Optical coherence tomography (OCT)-guided stent implantation vs. conventional angiography guided angioplasty.

CLI-randomized study CLI-OPCI (n = 670, 1:1) evaluated the impact of stent implantation guided by angiography and optical coherence tomography (OCT), versus angioplasty guided...

DESolve I FIM: Evaluation of a FIM trial results of a bioabsorbable stent (15 patients).

 This trial is a prospective evaluation of DESolveTM bioabsorbable coronary stent implantation in a 15 patient cohort enrolled in New Zealand and Belgium. At...

SMART: Manual Thrombectomy vs. Rheolytic Aspiration in ST-segment Elevation Acute Myocardial Infarction.

Dr. David Antoniucci presented the immediate results of randomized trial SMART SMART (n=80, 1:1) comparing manual thrombectomy (MAT) vs. rheolytic aspiration (RT) in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...